drugset / Trial / NCT03667001

Comparing Analgesic Efficacy of Systemic Lidocaine Against Placebo in General Anesthesia in Bariatric Surgery

NCT03667001 ↗

Phase 3 Completed 140 enrolled Miodrag Filipovic, Prof. Dr. med.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The investigators plan to evaluate the analgesic effect of systemic Lidocaine in addition to general anesthesia during bariatric surgery. Patients will be subdivided into a "Lidocaine group" and a "Control group". The primary outcome will be the proportion of patients suffering from higher pain intensity within the first four hours after bariatric surgery. Secondary outcomes include the average maximal pain intensity during first four hours and during 48 hours, total opiate consumption, occurence of postoperative nausea and vomiting, time to first defecation and total time spent in hospital.

Timeline

Start
2018-11-16
Primary completion
2021-04-01
Completion
2021-04-01

Outcome

Missed primary endpoint

paper proportion of any NRS >3 within first 4 h lidocaine group: 47/68 (69%) vs placebo group: 44/69 (63%), P=0.507 PMID 37183098 ↗

paper Lidocaine does not improve postoperative pain scores PMID 37183098 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 1.5 mg/kg Intravenous

Indications